Could gene therapy provide long-term protection against HIV?

Credit: NIAID/Flickr
HIV-infected T cell

FINDINGS

Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells not only destroyed the infected cells, they persisted for more than two years, suggesting the potential to create long-term immunity from the virus that causes AIDS.

BACKGROUND

Antiviral drugs can suppress the amount of HIV in the body to nearly undetectable levels, but only an effective immune response can eradicate the virus. Researchers have been seeking a way to improve the body’s ability to combat the virus by engineering blood-forming stem cells to specifically target and kill HIV-infected cells for the life of the individual. Although chimeric antigen receptor (CAR) T-cells have emerged as a powerful immunotherapy for various forms of cancer – and show promise in treating HIV-1 infection – the therapy may not impart long-lasting immunity. Researchers, physicians and patients need T cell-based products that can respond to malignant or infected cells that may reappear months or years after treatment.

METHOD

Because HIV uses CD4 to infect cells, the researchers used a CAR molecule that hijacks the essential interaction between HIV and the cell surface molecule CD4 to make stem cell-derived T-cells target infected cells. When the CD4 on the CAR molecule binds to HIV, other regions of the CAR molecule signal the cell to become activated and kill the HIV infected cell. The researchers found that, in test animals, modification of the blood-forming stem cells resulted in more than two years of stable production of CAR-expressing cells without any adverse effects. In addition, these cells were widely distributed throughout the lymphoid tissues and gastrointestinal tract, which are major anatomic sites for HIV replication and persistence in infected people. Most important, engineered CAR T-cells showed efficacy in attacking and killing HIV-infected cells.

IMPACT

These findings are the first to show that blood-forming stem cells can be modified with a CAR therapy that can safely engraft in the bone marrow, mature and become functional immune cells throughout the body. This could lead to the development of an approach allowing for safe, lifelong immunity to HIV. Such an approach is likely to work best when performed in combination with other treatment strategies, such as antiretroviral therapy. Researchers hope that this type of therapy could reduce infected individuals’ dependence on antiviral medications, lower the cost of therapy, and permit the possible eradication of HIV from its hiding places in the body. The approach also has potential against other infections or malignancies.

A key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear

Learn more: Gene Therapy Using CAR T-Cells Could Provide Long-Term Protection Against HIV

The Latest on: HIV gene therapy

[google_news title=”” keyword=”HIV gene therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

New study shows a single experimental shot reduces HIV levels 1,000-fold
on August 8, 2024 at 1:26 pm
A single shot of an experimental injection dramatically reduces levels of the monkey form of HIV in nonhuman primates for at least 30 weeks, according to a study published today in Science. The new ...
Beyond HIV testing: the case for sickle cell screening in Uganda
on August 6, 2024 at 6:57 pm
The genetic nature of the disease means that carriers of the trait can unknowingly pass it on to their children, potentially resulting in the birth of children with sickle cell disease. This ...
HIV and AIDS News
on August 6, 2024 at 5:00 pm
Children Surpass a Year of HIV Remission After Treatment Pause Mar. 7, 2024 — Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART ...
Can we conquer HIV?
on August 2, 2024 at 2:00 am
MELODY CHIRONDA | The world eagerly awaits the day when we can announce a cure for HIV. Reports now indicate that this day may be near. Several individuals have been cured of HIV around the world, ...
Seventh Person ‘Cured’ of HIV After Stem Cell Transplant
on July 30, 2024 at 7:30 am
A 60-year-old man in Germany has become at least the seventh person with HIV to be announced free of the virus after receiving a stem-cell transplant. But the man, who has been virus-free for close to ...
First-in-Human Trial of CRISPR Gene Therapy for HIV
on July 30, 2024 at 3:09 am
The CRISPR Cas system delivered by adeno-associated virus 9 gene therapy to treat HIV was able to target only the intended DNA and cleared the blood in 6 months.
Latest HIV Cure Case Comes With a Twist
on July 29, 2024 at 9:03 am
The newest stem cell recipient to test negative for HIV after cancer treatment had a donor with a single — rather than double — gene mutation that is opening the donor pool in renewed cure efforts.
Munich AIDS conference unveils new HIV cure case and bold global projections
on July 27, 2024 at 6:28 pm
This new finding suggested that effective HIV remission could be achieved with a broader pool of donors, which holds promise for future gene therapy-based HIV cure strategies. In addition to this ...
MIT Technology Review
on July 26, 2024 at 11:30 am
In a public interview, Chinese biophysicist He Jiankui said he is receiving offers of financial support from figures in the US.
'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV
on July 25, 2024 at 8:11 am
The next Berlin patient is a white male born in 1964 and diagnosed with HIV in 2009. Due to the treatment guidelines at the time, ART was not initiated until April 2015, Gaebler said, and the patient ...